21

Medlive Technology Co LtdHKG 2192 Stock Report

Last reporting period 31 Dec, 2023

Updated 01 Nov, 2024

Last price

Market cap $B

0.755

Micro

Exchange

XHKG - Hong Kong Exchange

2192.HK Stock Analysis

21

Uncovered

Medlive Technology Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

91/100

Moderate score

Market cap $B

0.755

Dividend yield

4.38 %

Shares outstanding

717.35 B

Medlive Technology Co., Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing and currently employs 614 full-time employees. The company went IPO on 2021-07-15. The firm mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The firm mainly conducts its business within domestic market.

View Section: Eyestock Rating